Form 8-K - Current report:
SEC Accession No. 0001193125-19-304799
Filing Date
2019-12-03
Accepted
2019-12-03 07:31:02
Documents
12
Period of Report
2019-12-03
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d842936d8k.htm   iXBRL 8-K 24665
  Complete submission text file 0001193125-19-304799.txt   147078

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dvax-20191203.xsd EX-101.SCH 3067
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20191203_lab.xml EX-101.LAB 18139
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20191203_pre.xml EX-101.PRE 11406
7 EXTRACTED XBRL INSTANCE DOCUMENT d842936d8k_htm.xml XML 3400
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 191264635
SIC: 2834 Pharmaceutical Preparations